Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin-Rong Yang

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Gut|May 6, 2010
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinomaXin-Rong Yang, Yang Xu, Bin Yu, et al.
Hepatology International|April 28, 2023
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1Jie Hu, Wei-Feng Liu, Xiang-Yu Zhang, et al.
Frontiers in Cellular and Infection Microbiology|July 5, 2022
Metagenomic Next-Generation Sequencing Versus Traditional Laboratory Methods for the Diagnosis and Treatment of Infection in Liver TransplantationJun-Feng Huang, Qing Miao, Jian-Wen Cheng, et al.
Journal of Cancer|November 3, 2021
Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver TransplantationAo Huang, De-Zhen Guo, Yu-Peng Wang, et al.
Gastroenterology|August 24, 2010
Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinomaJia-Chu Li, Xin-Rong Yang, Hai-Xiang Sun, et al.
Biochemical and Biophysical Research Communications|October 21, 2015
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinomaBo Hu, Ding Sun, Chao Sun, et al.
Hepatic Oncology|September 8, 2018
High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomyQiujin Shen, Xin-Rong Yang, Yexiong Tan, et al.
Ebiomedicine|November 12, 2020
Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinomaKai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, et al.
Clinical and Translational Medicine|July 24, 2020
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched studyPeng-Xiang Wang, Yun-Fan Sun, Kai-Qian Zhou, et al.
Oncology Letters|May 29, 2018
Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinomaXiao-Lu Ma, Jing Zhu, Jiong Wu, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Gut|May 6, 2010
High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinomaXin-Rong Yang, Yang Xu, Bin Yu, et al.
Hepatology International|April 28, 2023
Synthetic miR-26a mimics delivered by tumor exosomes repress hepatocellular carcinoma through downregulating lymphoid enhancer factor 1Jie Hu, Wei-Feng Liu, Xiang-Yu Zhang, et al.
Frontiers in Cellular and Infection Microbiology|July 5, 2022
Metagenomic Next-Generation Sequencing Versus Traditional Laboratory Methods for the Diagnosis and Treatment of Infection in Liver TransplantationJun-Feng Huang, Qing Miao, Jian-Wen Cheng, et al.
Journal of Cancer|November 3, 2021
Plasma MicroRNA Panel Predicts Early Tumor Recurrence in Patients with Hepatocellular Carcinoma after Liver TransplantationAo Huang, De-Zhen Guo, Yu-Peng Wang, et al.
Gastroenterology|August 24, 2010
Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinomaJia-Chu Li, Xin-Rong Yang, Hai-Xiang Sun, et al.
Biochemical and Biophysical Research Communications|October 21, 2015
A polymeric nanoparticle formulation of curcumin in combination with sorafenib synergistically inhibits tumor growth and metastasis in an orthotopic model of human hepatocellular carcinomaBo Hu, Ding Sun, Chao Sun, et al.
Hepatic Oncology|September 8, 2018
High level of serum protein DKK1 predicts poor prognosis for patients with hepatocellular carcinoma after hepatectomyQiujin Shen, Xin-Rong Yang, Yexiong Tan, et al.
Ebiomedicine|November 12, 2020
Effect of surgical margin on recurrence based on preoperative circulating tumor cell status in hepatocellular carcinomaKai-Qian Zhou, Yun-Fan Sun, Jian-Wen Cheng, et al.
Clinical and Translational Medicine|July 24, 2020
Circulating tumor cells are an indicator for the administration of adjuvant transarterial chemoembolization in hepatocellular carcinoma: A single-center, retrospective, propensity-matched studyPeng-Xiang Wang, Yun-Fan Sun, Kai-Qian Zhou, et al.
Oncology Letters|May 29, 2018
Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinomaXiao-Lu Ma, Jing Zhu, Jiong Wu, et al.
Pageof 12